International Financing Session at BioContact Québec 2007



    MONTREAL, Oct. 3 /CNW Telbec/ - BioContact Québec will host two panels of
leading figures in the U.S. financial communities. All focus completely or in
large measure on life sciences and all share a common interest in expanding
their involvement with Canadian companies.
    The first panel will consist of venture capital and private equity
investors. The second will include investment bankers of various sizes and
interests, actively engaged in raising funds for Canadian life science
companies. Both panels will focus on investment criteria, stage of
development, terms and substantive interests.

    Venture Capital

    James Garvey, Managing Partner - SV Life Sciences
    Dominique Semon, chief Investment Officer - Merlin Biomed Group
    Ron Laufer, Managing Director, Lilly BioVentures
    Ken Sorensen, Managing Partner, Array Capital LLC
    Art Pappas, Managing Partner, Am PappasVentures

    Investment Banking

    Stuart Barich, Managing Director - Oppenheimer & Co.
    Edwin Gordon, Managing Director - Merriman Curhan Ford & Co.
    Mark Epstein, Managing Director - Bank of America Securities LLC
    Michael K. Levitan, , Managing Director - Trout Capital LLC
    Jonathan Gertler, Managing Partner, Leerink Swann & Co.
    Len Schleicher, Vice President, Capital Markets - Taglich Brothers

    The event will be held at Le Château Frontenac (Salon Rose) in Quebec
City, at 2:00 pm.




For further information:

For further information: Hélène Turcotte, Press Room Coordinator,
BioContact 2007, (418) 573-4046

Organization Profile

BioContact Quebec

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890